14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $3.81 $4.81 Thursday, 2nd May 2024 NVAX stock ended at $4.71. This is 0.86% more than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 3.80% from a day low at $4.60 to a day high of $4.78.
90 days $3.53 $6.05
52 weeks $3.53 $11.36

Historical Novavax Inc prices

Date Open High Low Close Volume
Sep 27, 2023 $7.18 $7.38 $7.03 $7.19 4 095 277
Sep 26, 2023 $7.20 $7.54 $7.05 $7.11 7 087 386
Sep 25, 2023 $7.07 $7.57 $6.90 $7.31 7 995 567
Sep 22, 2023 $6.87 $7.16 $6.81 $7.13 6 442 593
Sep 21, 2023 $6.94 $7.04 $6.73 $6.81 9 309 649
Sep 20, 2023 $7.73 $7.75 $6.94 $7.05 14 191 602
Sep 19, 2023 $7.41 $7.75 $7.36 $7.68 10 203 694
Sep 18, 2023 $7.77 $7.86 $7.39 $7.41 6 562 143
Sep 15, 2023 $7.89 $8.08 $7.67 $7.71 10 295 418
Sep 14, 2023 $7.42 $8.02 $7.30 $7.99 13 207 533
Sep 13, 2023 $7.89 $7.93 $7.34 $7.36 12 387 586
Sep 12, 2023 $7.86 $8.33 $7.44 $7.91 11 881 559
Sep 11, 2023 $9.02 $9.00 $7.73 $7.82 18 739 124
Sep 08, 2023 $9.03 $9.75 $8.90 $8.97 11 028 384
Sep 07, 2023 $9.82 $9.98 $8.70 $9.15 19 536 040
Sep 06, 2023 $9.07 $10.30 $9.04 $9.74 27 978 192
Sep 05, 2023 $8.32 $9.27 $8.25 $9.05 19 534 499
Sep 01, 2023 $8.04 $8.47 $8.02 $8.21 7 976 155
Aug 31, 2023 $8.36 $8.57 $8.00 $8.00 7 599 003
Aug 30, 2023 $8.30 $8.60 $8.18 $8.36 6 583 928
Aug 29, 2023 $8.24 $8.45 $8.11 $8.30 5 867 501
Aug 28, 2023 $8.24 $9.04 $8.08 $8.35 14 403 241
Aug 25, 2023 $8.24 $8.32 $8.00 $8.05 5 837 434
Aug 24, 2023 $8.99 $9.03 $7.92 $8.23 10 872 690
Aug 23, 2023 $9.10 $9.53 $8.70 $9.01 12 658 897
Click to get the best stock tips daily for free!

About Novavax Inc

Novavax Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical tria... NVAX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT